Next, to study the relationship between the differentiation signature of the cancer cells and characteristics of the corresponding immune microenvironments, we divided the patients into the immune-poor type and immune-rich type according to the density of tumor-infiltrating CD8+ T cells [39]. The gene discussed is CD8A; the disease is cancer.